ANI Pharmaceuticals, Inc. has grown revenue 37% a year over three years and 34% a year over five. Revenue growth, 3-year annual rate: +37% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +34%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

ANIPANI Pharmaceuticals, Inc.

HealthcareUSD

$74.57

$70.4952 weeks$98.81

Is it growing?

Is ANIP growing?

ANI Pharmaceuticals, Inc. has grown revenue 37% a year over three years and 34% a year over five.

+37%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +34%
Revenue growth, 5-year rate · +37% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›